Drugs / FK614
last change Mar 2006 re-read 3 minutes ago

FK614

Developed for
type 2 diabetes mellitus
Investigated by
Astellas Pharma Inc · Astellas Pharma US, Inc.

Trials 1

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00036192 Feb 2002 → Mar 2006 type 2 diabetes mellitus Astellas Pharma Inc Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FK614 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00036192 ↗